Upregulation of LINC00665 Correlates with Aggressive Hepatocellular Carcinoma and Poor Prognosis.
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 44.0%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
[INTRODUCTION] Recent research has revealed that LINC00665 is crucial for cancer cell proliferation and metastasis.
APA
Zhong Q, Zhao B, et al. (2026). Upregulation of LINC00665 Correlates with Aggressive Hepatocellular Carcinoma and Poor Prognosis.. Combinatorial chemistry & high throughput screening. https://doi.org/10.2174/0113862073389839251128150111
MLA
Zhong Q, et al.. "Upregulation of LINC00665 Correlates with Aggressive Hepatocellular Carcinoma and Poor Prognosis.." Combinatorial chemistry & high throughput screening, 2026.
PMID
41830138 ↗
Abstract 한글 요약
[INTRODUCTION] Recent research has revealed that LINC00665 is crucial for cancer cell proliferation and metastasis. Despite its presence, the role of LINC00665 in diagnosing and predicting outcomes in HCC remains poorly studied.
[METHODS] This study analyzed LINC00665 expression in TCGA and GTEx datasets and examined its association with clinicopathological characteristics. The association between LINC00665 and HCC prognosis was examined through survival and Cox regression analyses. To investigate the pathways associated with LINC00665 in HCC, we conducted GSEA. Additionally, the association between LINC00665 and immune cell infiltration was assessed through a comprehensive immune landscape analysis. Finally, multiple in vitro experiments validated the function of LINC00665 in accelerating HCC progression.
[RESULTS] Our study demonstrated a significant upregulation of LINC00665 in hepatocellular carcinoma (HCC). Elevated LINC00665 expression was strongly associated with adverse clinicopathological features, poor prognosis, and an immunosuppressive tumor microenvironment. Gene set enrichment analysis (GSEA) revealed that LINC00665 participates in multiple established oncogenic pathways. Furthermore, we observed noTable alterations in immune cell populations associated with its expression. Functional assays showed that silencing LINC00665 significantly inhibited tumor cell proliferation and invasive potential, highlighting its role as a potential therapeutic target in HCC.
[DISCUSSION] This study establishes LINC00665 as a critical oncogenic driver and prognostic biomarker in HCC, closely associated with tumor proliferation, metastasis, and an immunosuppressive microenvironment. While these findings underscore its clinical significance, further experimental and clinical validation is necessary to translate this insight into effective therapeutic strategies.
[CONCLUSIONS] To sum up, LINC00665 has potential as an oncogenic biomarker in several cancers, underscoring the need for further study.
[METHODS] This study analyzed LINC00665 expression in TCGA and GTEx datasets and examined its association with clinicopathological characteristics. The association between LINC00665 and HCC prognosis was examined through survival and Cox regression analyses. To investigate the pathways associated with LINC00665 in HCC, we conducted GSEA. Additionally, the association between LINC00665 and immune cell infiltration was assessed through a comprehensive immune landscape analysis. Finally, multiple in vitro experiments validated the function of LINC00665 in accelerating HCC progression.
[RESULTS] Our study demonstrated a significant upregulation of LINC00665 in hepatocellular carcinoma (HCC). Elevated LINC00665 expression was strongly associated with adverse clinicopathological features, poor prognosis, and an immunosuppressive tumor microenvironment. Gene set enrichment analysis (GSEA) revealed that LINC00665 participates in multiple established oncogenic pathways. Furthermore, we observed noTable alterations in immune cell populations associated with its expression. Functional assays showed that silencing LINC00665 significantly inhibited tumor cell proliferation and invasive potential, highlighting its role as a potential therapeutic target in HCC.
[DISCUSSION] This study establishes LINC00665 as a critical oncogenic driver and prognostic biomarker in HCC, closely associated with tumor proliferation, metastasis, and an immunosuppressive microenvironment. While these findings underscore its clinical significance, further experimental and clinical validation is necessary to translate this insight into effective therapeutic strategies.
[CONCLUSIONS] To sum up, LINC00665 has potential as an oncogenic biomarker in several cancers, underscoring the need for further study.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Associations between respiratory diseases and lung cancer risk: a secondary analysis of the large-scale prospective UK biobank cohort.
- Correction: Proteomic-based stratification of intermediate-risk prostate cancer patients.
- Dynamic postoperative prognosis and follow-up optimization for gastric cancer patients after neoadjuvant therapy: a multicenter retrospective study.
- [Long-term oncological safety of robotic total gastrectomy for locally advanced proximal gastric cancer: a 5-year noninferiority comparison based on the FUGES-014 study].
- Comparison of a submucosal and subserosal approach in ICG-guided laparoscopic lymphadenectomy in gastric cancer patients: long-term outcomes of a phase 3 randomized clinical trial.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Raman Spectroscopic Signatures of Hepatic Carcinoma: Progress and Future Prospect.
- Nanotechnology-Assisted Molecular Profiling: Emerging Advances in Circulating Tumor DNA Detection.
- The role of disulfidptosis-driven tumor microenvironment remodeling in pancreatic cancer progression.
- SMURF2 in Anticancer Therapy: Dual Role in Carcinogenesis and Theranostics.
- Safe discharge on the second postoperative day after major colorectal surgery: a decision-making strategy based on quantitative serological data.